331A — Medix Cashflow Statement
0.000.00%
- ¥4bn
- ¥486m
- ¥4bn
- 82
- 86
- 20
- 71
Annual cashflow statement for Medix, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | Tanshin |
Standards: | JAS | JAS | — |
Status: | Final | Final | Final |
Net Income/Starting Line | 637 | 788 | 952 |
Depreciation | |||
Non-Cash Items | 147 | -30.6 | -131 |
Unusual Items | |||
Other Non-Cash Items | |||
Changes in Working Capital | -297 | -123 | -366 |
Change in Accounts Receivable | |||
Change in Prepaid Expenses | |||
Change in Accounts Payable | |||
Change in Accrued Expenses | |||
Change in Other Liabilities | |||
Other Operating Cash Flow | |||
Cash from Operating Activities | 558 | 676 | 500 |
Capital Expenditures | -44.8 | -44.1 | -17.2 |
Purchase of Fixed Assets | |||
Purchase / Acquisition of Intangibles | |||
Other Investing Cash Flow Items | 73.4 | 52.6 | 432 |
Sale/Maturity of Investment | |||
Purchase of Investments | |||
Other Investing Cash Flow | |||
Cash from Investing Activities | 28.7 | 8.51 | 414 |
Financing Cash Flow Items | -28 | -45.5 | -60.2 |
Other Financing Cash Flow | |||
Net Issuance / Retirement of Stock | |||
Net Issuance / Retirement of Debt | |||
Cash from Financing Activities | -0.544 | -218 | 76.3 |
Beginning Cash Balance | |||
Ending Cash Balance | |||
Net Change in Cash | 586 | 467 | 991 |